BE728658A - - Google Patents

Info

Publication number
BE728658A
BE728658A BE728658DA BE728658A BE 728658 A BE728658 A BE 728658A BE 728658D A BE728658D A BE 728658DA BE 728658 A BE728658 A BE 728658A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE728658A publication Critical patent/BE728658A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
BE728658D 1968-03-06 1969-02-19 BE728658A (e)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB00906/68A GB1203691A (en) 1968-03-06 1968-03-06 New disubstituted n-amino indoline derivatives and process for preparing them

Publications (1)

Publication Number Publication Date
BE728658A true BE728658A (e) 1969-08-19

Family

ID=9976474

Family Applications (1)

Application Number Title Priority Date Filing Date
BE728658D BE728658A (e) 1968-03-06 1969-02-19

Country Status (13)

Country Link
US (1) US3565911A (e)
BE (1) BE728658A (e)
CH (1) CH507940A (e)
DE (1) DE1909180A1 (e)
DK (1) DK126193B (e)
ES (1) ES364421A1 (e)
FI (1) FI50119C (e)
FR (1) FR2003311A1 (e)
GB (1) GB1203691A (e)
IT (1) IT8049196A0 (e)
NL (1) NL145226B (e)
NO (1) NO128068B (e)
SE (1) SE334887B (e)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112111A (en) * 1975-02-26 1978-09-05 Sandoz Ltd. Indolinylguanidines
IT1113879B (it) * 1979-03-15 1986-01-27 Farmatis Spa Derivato isoindolinico,processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo
LU82949A1 (fr) * 1980-11-20 1981-06-04 Usv Pharma Corp Nouveaux amino-benzamides,leur procede de preparation et leur application au traitement de l'hypertension
DE3172386D1 (en) * 1980-12-22 1985-10-24 Usv Pharma Corp Synthesis of indolines
JPS57206657A (en) * 1981-06-16 1982-12-18 Mitsui Toatsu Chem Inc Sulfamoylbenzoic acid derivative and remedying composition containing said derivative as active component
FR2529785A1 (fr) * 1982-07-09 1984-01-13 Adir Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne
FR2663324B1 (fr) * 1990-06-14 1992-09-04 Adir Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide.
FR2663325B1 (fr) * 1990-06-14 1992-09-04 Adir Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide a partir de la 2,3-dihydro 2-methyl 1h-indole et de l'acide hydroxylamine-o-sulfonique.
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
US5319096A (en) * 1992-04-03 1994-06-07 Hoechst-Roussel Pharmaceuticals Inc. (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
JP2008520578A (ja) * 2004-11-15 2008-06-19 ニトロメッド インコーポレーティッド 複素環式の酸化窒素供与体基を含む利尿化合物、組成物および使用方法
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
FR2924713B1 (fr) * 2007-12-11 2010-01-29 Servier Lab Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2575808A1 (en) 2010-05-28 2013-04-10 Mahmut Bilgic Combination of antihypertensive agents
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof
TW202314018A (zh) * 2021-06-21 2023-04-01 荷蘭商Asm Ip私人控股有限公司 用於形成包含氧化銦鎵鋅的層之反應器系統及方法
WO2023001880A1 (en) 2021-07-22 2023-01-26 Krka, D. D., Novo Mesto Bilayer tablet comprising telmisartan and indapamide
EP4295839A1 (en) 2022-06-20 2023-12-27 KRKA, d.d., Novo mesto Combination of valsartan and indapamide
EP4374855A1 (en) 2022-11-22 2024-05-29 KRKA, D.D., Novo Mesto Pharmaceutical dosage form of candesartan and indapamide

Also Published As

Publication number Publication date
CH507940A (fr) 1971-05-31
IT8049196A0 (it) 1980-07-09
DK126193B (da) 1973-06-18
NO128068B (e) 1973-09-24
US3565911A (en) 1971-02-23
GB1203691A (en) 1970-09-03
FI50119C (fi) 1975-12-10
DE1909180A1 (de) 1970-07-02
SE334887B (e) 1971-05-10
FI50119B (e) 1975-09-01
NL145226B (nl) 1975-03-17
ES364421A1 (es) 1971-02-01
FR2003311A1 (e) 1969-11-07
NL6903421A (e) 1969-09-09

Similar Documents

Publication Publication Date Title
FI50119B (e)
AU5506869A (e)
AU5184069A (e)
AU6168869A (e)
AU6171569A (e)
AU4811568A (e)
AU421558B1 (e)
AU4744468A (e)
AU4464266A (e)
BE727938A (e)
AU5758767A (e)
BE630165A (e)
BE642636A (e)
BE708888A (e)
AU479894A (e)
AU4270368A (e)
AU479393A (e)
BE708933A (e)
AU463027A (e)
AU4558658A (e)
AU4503667A (e)
BE709479A (e)
AU4224469A (e)
BE728436A (e)
BE728425A (e)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: SOC FRANCAISE DE RECHERCHE MEDICALE

Effective date: 19890219

Owner name: SCIENCE UNION & CIE

Effective date: 19890219